Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
Clin Toxicol (Phila) ; 51(8): 783-8, 2013.
Article in English | MEDLINE | ID: mdl-23962099

ABSTRACT

CONTEXT: Envenomation by the Eastern coral snake is rare but may be associated with significant morbidity. While effective, acquisition of North American Coral Snake Antivenin (NACSAV) is difficult because production was discontinued for many years. OBJECTIVE: The purpose of this study is to characterize coral snake exposures in Florida and determine the effects of varying treatment paradigms on patient outcomes. METHODS: This study is an observational case series of cases received at Florida poison centers. Included cases were Eastern coral snake exposures occurring between January 1, 1998 and October 31, 2010. Excluded cases included those found to be unrelated or those not followed for at least 24 h post envenomation. Case comments were reviewed to obtain data. Comparisons were made between asymptomatic patients receiving empiric antivenom therapy (empiric group) and those asymptomatic patients who received antivenom upon developing signs of systemic envenomation (withhold group). RESULTS: Of the 553 cases identified, 387 were included in the final analysis. According to case comments, 56.3% of patients had no reported systemic symptoms. Most commonly, patients were reported to have pain (40.6%), paresthesias (28.4%), nausea (12.7%), and emesis (11.4%). NACSAV was administered to 252 patients (65%). Of those patients receiving NACSAV, 18.25% were reported to have had an adverse reaction. Patients in the withhold group (n = 106) had significantly fewer minor, moderate, and major outcomes than patients in the empiric group (n = 134, p < 0.01). DISCUSSION: While patients in the withhold group had favorable outcomes compared with those in the empiric group, this strategy cannot be applied to all patients presenting asymptomatic to healthcare facilities due to study limitations. CONCLUSION: Further studies are needed to determine what treatment strategy is most appropriate for asymptomatic patients presenting to healthcare facilities.


Subject(s)
Antivenins/therapeutic use , Elapid Venoms/poisoning , Elapidae , Poison Control Centers/statistics & numerical data , Snake Bites/therapy , Adolescent , Adult , Aged , Animals , Antivenins/administration & dosage , Antivenins/adverse effects , Child , Child, Preschool , Cohort Studies , Female , Florida/epidemiology , Humans , Male , Middle Aged , Retrospective Studies , Snake Bites/epidemiology , Treatment Outcome , Young Adult
2.
Mil Med ; 166(5): 369-74, 2001 May.
Article in English | MEDLINE | ID: mdl-11370195

ABSTRACT

The threat of bioterrorism in the United States is increasing. Health professionals, especially "front-line" practitioners, must be able to recognize the potential for major impacts from a bioterrorism event. Although an effective attack could produce numbers of casualties equivalent to those resulting from a nuclear weapon, an unannounced attack would be unlikely to be recognized immediately. Health workers may be the first to recognize an attack. However, only limited assistance is available to aid local community medical organizations in planning for bioterrorism. Military medical personnel have had more experience in planning for terrorist activities than many of their civilian colleagues. Their experience may be invaluable to local civilian treatment facilities in developing practical plans to meet the unique aspects of bioterrorism. In addition to considering agent-specific medical problems and requirements, it is particularly important for plans to address command and control, communication, and coordination if the resultant response is to be effective.


Subject(s)
Biological Warfare/prevention & control , Bioterrorism/prevention & control , Disaster Planning/methods , Military Personnel , Civil Defense/organization & administration , Communicable Diseases , Disease Outbreaks/prevention & control , Emergency Medical Services/methods , Hazardous Substances , Humans
3.
Arch Ophthalmol ; 118(12): 1653-9, 2000 Dec.
Article in English | MEDLINE | ID: mdl-11115259

ABSTRACT

CONTEXT: Unusual cataracts (flecks) have been reported to occur at very low levels of trinitrotoluene exposure, but prevalence estimates vary widely. Cataracts have not been reported among workers in the United States exposed to organic nitrate explosives. OBJECTIVES: To determine the prevalence of unusual cataracts in a population of workers in the United States exposed to organic nitrate explosives, to determine whether associations exist with reported cataract risk factors, and to determine if other eye effects (eg, retinal hemorrhage) are associated with exposure. DESIGN: Cohort prevalence study. SETTING: A university-based ophthalmologic clinic. SUBJECTS: Sixty-one workers from an explosives plant comprised the exposed group. The comparison group consisted of 56 workers using chemicals other than organic nitrate explosives. OUTCOME MEASURES: The primary outcome measure was opacifications (flecks) of the crystalline lens, graded clinically on a scale of 0 to 4 +. Additional measures included visual acuity, applanation tonometry, and clinical evaluation using standard examination techniques. RESULTS: Sixty-three percent of the workers had anterior cortical lens opacifications in a pattern of peripheral flecks. Exposed subjects were 18 times more likely to exhibit changes than those not exposed, a statistically significant association (95% confidence interval [CI], 5.0-65.0; P<.001). A statistically significant association with the duration of exposure was also found. CONCLUSIONS: Asymptomatic, low-grade cataracts (flecks) were identified in 63% of the workers exposed to pentolite. No other eye effects were found to be associated with exposure. Cataracts were not associated with other known risk factors, but were associated with the duration of exposure. Biomicroscopy is widely available and useful for detecting changes in the asymptomatic stages.


Subject(s)
Cataract/chemically induced , Lens, Crystalline/drug effects , Occupational Diseases/chemically induced , Occupational Exposure/adverse effects , Pentaerythritol Tetranitrate/adverse effects , Trinitrotoluene/adverse effects , Adult , Cataract/diagnosis , Cataract/epidemiology , Cohort Studies , Drug Combinations , Explosions , Female , Humans , Intraocular Pressure , Lens, Crystalline/pathology , Male , Middle Aged , Occupational Diseases/diagnosis , Occupational Diseases/epidemiology , Odds Ratio , Ophthalmoscopy , Prevalence , Reflex, Pupillary , Refraction, Ocular , Risk Factors , Utah/epidemiology , Visual Acuity , Visual Fields
4.
Dermatology ; 200(2): 124-8, 2000.
Article in English | MEDLINE | ID: mdl-10773700

ABSTRACT

BACKGROUND: Although effective at treating mycosis fungoides (MF), nitrogen mustard (HN(2)) creates potential exposure risks to those who administer it, including health care workers and family members. OBJECTIVE: The main objective was to examine the potential for nontarget individuals to be exposed to HN(2) vapors during and shortly after treatment with HN(2) in a home environment. METHODS: Air concentrations of HN(2) were measured during the topical treatment of MF in a patients home. RESULTS: The results demonstrate that eye and mucous membrane irritation may occur at HN(2) levels commonly encountered during the treatment of MF in the home, hospital or health clinic. Because no exposure thresholds have been developed for HN(2), the exposure thresholds of a surrogate chemical (sulfur mustard) were used. CONCLUSIONS: The study findings show that eye and mucous membrane irritation may occur at HN(2) levels below the exposure thresholds of the surrogate chemical. Recommendations for controlling exposures to HN(2) in the home are given.


Subject(s)
Air Pollution, Indoor/analysis , Antineoplastic Agents, Alkylating/analysis , Mechlorethamine/analysis , Mycosis Fungoides/drug therapy , Skin Neoplasms/drug therapy , Administration, Topical , Antineoplastic Agents, Alkylating/administration & dosage , Environmental Exposure , Housing , Humans , Mechlorethamine/administration & dosage
SELECTION OF CITATIONS
SEARCH DETAIL